Mechanical & Materials Engineering, Department of

 

Date of this Version

4-21-2023

Citation

Chen T, Meng F, Ying B and Zhu X (2023), Editorial: Disease biomarker analysis based on optical biosensing. Front. Chem. 11:1205533. doi: 10.3389/fchem.2023.1205533

Comments

Open access.

Abstract

Disease biomarker analysis has become a crucial tool for diagnosing and evaluating disease prognosis, especially with the increasing understanding of diseases at the molecular level. Abnormalities in various biomarkers can indicate diseased states, and can be used to rapidly and specifically detect and quantify diseases using optical biosensing techniques (Gao et al., 2023). Optical biosensing techniques have several advantages over traditional methods including higher sensitivity, specificity, and faster analysis times (Plikusiene and Ramanaviciene, 2023). It also allows for non-invasive sample collection. With advancements in optical biosensing technology, many medical conditions including cancers, infectious diseases, and autoimmune disorders can be accurately diagnosed and efficiently treated (Singh et al., 2023; Tang et al., 2023). The combination of optical biosensing with emerging technologies such as material science, optics, and electronics has further accelerated its development in biomarker analysis (Qureshi et al., 2022). Interdisciplinary collaboration between experts in fields such as physics, chemistry, bioengineering, and medicine has helped pave the way for novel optical biosensing technologies as well as improving existing ones. Continued interdisciplinary collaboration is essential in advancing the field of disease biomarker analysis based on optical biosensing. This exciting area of research holds great potential for the future of personalized and precision medicine, and will likely lead to more effective disease diagnoses and treatments (Duo et al., 2023).

Download

Share

COinS